Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Other companies in Denali Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Immunome Inc (NASDAQ:IMNM), Sarepta Therapeutics Inc (NASDAQ:SRPT), Ascentage Pharma Group International (NASDAQ:AAPG) and Mesoblast Ltd (NASDAQ:MESO).
Denali Therapeutics has a consensus price target of $35.28.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $17.56 last updated December 16, 2025 at 4:14 PM EST.
There are no upcoming dividends for Denali Therapeutics.
Denali Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Denali Therapeutics.
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.